Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

Clinical trial NCT05531422 · COMPLETED

Trial details

NCT number: NCT05531422
Sponsor: Lee's Pharmaceutical Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breakthrough Cancer Pain

Start date: 2021-10-20
Primary completion: 2023-03-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.